Overview of Nosocomial Infections Caused by Gram-Negative Bacilli
The DOI matches its Crossref record; 23 of the 26 references it cites were found in a registry or an index.
Abstract
We analyzed data from the National Nosocomial Infections Surveillance (NNIS) System from 1986-2003 to determine the epidemiology of gram-negative bacilli in intensive care units (ICUs) for the most frequent types of hospital-acquired infection: pneumonia, surgical site infection (SSI), urinary tract infection (UTI), and bloodstream infection (BSI). We analyzed >410,000 bacterial isolates associated with hospital-acquired infections in ICUs during 1986-2003. In 2003, gram-negative bacilli were associated with 23.8% of BSIs, 65.2% of pneumonia episodes, 33.8% of SSIs, and 71.1% of UTIs. The percentage of BSIs associated with gram-negative bacilli decreased from 33.2% in 1986 to 23.8% in 2003. The percentage of SSIs associated with gram-negative bacilli decreased from 56.5% in 1986 to 33.8% in 2003. The percentages pneumonia episodes and UTIs associated with gram-negative bacilli remained constant during the study period. The proportion of ICU pneumonia episodes associated with Acinetobacter species increased from 4% in 1986 to 7.0% in 2003 (P<.001, by the Cochran-Armitage chi2 test for trend). Significant increases in resistance rates were uniformly seen for selected antimicrobial-pathogen combinations. Gram-negative bacilli are commonly associated with hospital-acquired infections in ICUs. The proportion of Acinetobacter species associated with ICU pneumonia increased from 4% in 1986 to 7.0% in 2003.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As a group, these organisms are the most common etiology of nosocomial infections, including most cases of hospital-acquired pneumonia, ventilator-associated pneumonia and healthcare-associated pneumonia, and they are important causes of morbidity and death in hospitalized patients (1).”
From Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia (2017) · cites this paper as [1]
Citations
Cites
Vincent, J.-L. (1995) · JAMA · doi:10.1001/jama.1995.03530080055041 · Cited by 1,632 · cited 1×
“A recent review by Archibald [9] showed that the types of pathogens encountered in health care institutions in North America, Europe, Asia, Australia, and even Africa are, for the most part, similar [10-14].”
Hospital Epidemiology and Infection Control
Mayhall, C. G. (2011) · Cited by 1,179
National nosocomial infections surveillance system (NNIS): Description of surveillance methods
Emori, T. G., Culver, D. H., Horan, T. C., Jarvis, W. R., White, J. W., Olson, D. R., Banerjee, S., Edwards, J. R., Martone, W. J., Gaynes, R. P., et al. (1991) · American Journal of Infection Control · doi:10.1016/0196-6553(91)90157-8 · Cited by 832
Self-citationSurveillance nosokomialer Infektionen
Gastmeier (2004) · Therapeutische Umschau · doi:10.1024/0040-5930.61.3.204 · Cited by 509
Epidemiology and control of nosocomial infections in adult intensive care units
Weinstein, R. A. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90366-6 · Cited by 300 · cited 1×
“the 4 most frequent types of hospital-acquired infection: pneumonia, surgical site infection (SSI), urinary tract infection (UTI), and bloodstream infection (BSI) [1].”
BackgroundSelf-citationMultidrug-Resistant Acinetobacter baumannii
Abbo, A., Navon-Venezia, S., Hammer-Muntz, O., Krichali, T., Siegman-Igra, Y., & Carmeli, Y. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1101.040001 · Cited by 285 · cited 1×
“Acinetobacter organisms are intrinsically resistant to many antimicrobials and can acquire resistance to others [7].”
BackgroundHOSPITAL ACQUIRED INFECTIONS: KNOWLEDGE ABOUT IT AND ITS PREVENTION
QAYYUM, S., WAQAS, B., & SATTAR, A. (2010) · The Professional Medical Journal · doi:10.29309/tpmj/2010.17.02.2211 · Cited by 256
MAGNITUDE AND PREVENTION OF NOSOCOMIAL INFECTIONS IN THE INTENSIVE CARE UNIT
Fridkin, S. K., Welbel, S. F., & Weinstein, R. A. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70366-4 · Cited by 225 · cited 1×
“A recent review by Archibald [9] showed that the types of pathogens encountered in health care institutions in North America, Europe, Asia, Australia, and even Africa are, for the most part, similar [10-14].”
BackgroundSelf-citationStreit, J. M., Jones, R. N., Sader, H. S., & Fritsche, T. R. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.12.019 · Cited by 191
Syncope and orthostatic hypotension
Atkins, D., Hanusa, B., Sefcik, T., & Kapoor, W. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90012-m · Cited by 172
Research works printed but not linked: 2
- 1991, The American journal of medicine, 91, 86
- Richards, 2003, Annals of surgery, 237, 358, 10.1097/00000658-200303000-00009 · doi:10.1097/00000658-200303000-00009
Cited by
Items 301–400 of 1,000
Michalopoulos, A. S., Falagas, M. E., Karatza, D. C., Alexandropoulou, P., Papadakis, E., Gregorakos, L., Chalevelakis, G., & Παππάς, Γ. (2010) · American Journal of Infection Control · doi:10.1016/j.ajic.2010.06.017 · Cited by 57
Kılıç, A., Li, H., Mellmann, A., BAŞUSTAOĞLU, A. C., Kul, M., Şenses, Z., Aydoğan, H., Stratton, C. W., Harmsen, D., & Tang, Y. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01876-07 · Cited by 57
“National Nosocomial Infections Surveillance data from hospitals in 2003 (15).”
BackgroundMigiyama, Y., Yanagihara, K., Kaku, N., Harada, Y., Yamada, K., Nagaoka, K., Morinaga, Y., Akamatsu, N., Matsuda, J., Izumikawa, K., et al. (2015) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2014.573 · Cited by 57
“aeruginosa can also invade the bloodstream from these sites, resulting in a systemic infection called bacteremia (1).”
BackgroundThe Use of Carbapenems in the Treatment of Serious Infections
Baughman, R. P. (2009) · Journal of Intensive Care Medicine · doi:10.1177/0885066609335660 · Cited by 62
“However, as a class, gram negatives still represent at least half of the known pathogens causing nosocomial pneumonia.(21) While P aeruginosa remains the most common gramnegative pathogen, there has been a significant increase in the incidence of pneumonia caused by Acinetobacter subspecies.”
BackgroundAntibiotic Stewardship in Orthopaedic Surgery: Principles and Practice
Campbell, K. A., Stein, S., Looze, C. A., & Bosco, J. A. (2014) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-22-12-772 · Cited by 56
Manzur, A., Tubau, F., Pujol, M., Calatayud, L., Domínguez, M. Á., Peña, C., Sora, M., Gudiol, F., & Ariza, J. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02546-06 · Cited by 56
Cavalu, S. D., Elbaramawi, S. S., Eissa, A. G., Radwan, M. F., Ibrahim, T. S., Khafagy, E., Lopes, B. S., Ali, M. A. M., Hegazy, W. A. H., & Elfaky, M. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113088 · Cited by 58
RetractedRecent Advances in Nanozyme-Mediated Strategies for Pathogen Detection and Control
Ma, T., Huang, K., & Cheng, N. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713342 · Cited by 58
Management and prevention of ventilator-associated pneumonia caused by multidrug-resistant pathogens
Grgurich, P. E., Hudcova, J., Lei, Y., Sarwar, A., & Craven, D. E. (2012) · Expert Review of Respiratory Medicine · doi:10.1586/ers.12.45 · Cited by 64
Huang, C.-C., Chen, Y.-S., Toh, H. S., Lee, Y.-L., Liu, Y.-M., Ho, C., Lu, P., Liu, C.-E., Chen, Y., Wang, J.-H., et al. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(12)70003-1 · Cited by 55
Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination
Bounthavong, M., Hsu, D. I., & Hong, M.-C. (2013) · Infection and Drug Resistance · doi:10.2147/idr.s36140 · Cited by 55
Koomanachai, P., Bulik, C. C., Kuti, J. L., & Nicolau, D. P. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.04.003 · Cited by 58
Recovery ofPseudomonas aeruginosaculturability following copper- and chlorine-induced stress
Bédard, É., Charron, D., Lalancette, C., Déziel, É., & Prévost, M. (2014) · FEMS Microbiology Letters · doi:10.1111/1574-6968.12494 · Cited by 70
“Pseudomonas aeruginosa is an important source of nosocomial infections and the most frequently recovered Gram-negative bacterium from patients with nosocomial pneumonia in the USA (Weinstein et al., 2005).”
BackgroundHeteroresistance to carbapenems in invasive Pseudomonas aeruginosa infections
He, J., Jia, X., Yang, S., Xu, X., Sun, K., Li, C., Yang, T., & Zhang, L. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.10.014 · Cited by 55
Dikshit, N., Kale, S. D., Khameneh, H. J., Balamuralidhar, V., Tang, C.-Y., Kumar, P., Lim, T.-P., Tan, T. T., Kwa, A. L., Mortellaro, A., et al. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.50 · Cited by 56
Zhu, Z., Zhang, Y., Bao, L., Chen, J., Duan, S., Chen, S.-C., Xu, P., & Wang, W. (2021) · Environmental Science Nano · doi:10.1039/d0en01230k · Cited by 63
Xi, C., & Wu, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013355 · Cited by 59
Cuttelod, M., Senn, L., Terletskiy, V. P., Nahimana, I., Pétignat, C., Eggimann, P., Billé, J., Prod’hom, G., Zanetti, G. M. R., & Blanc, D. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03164.x · Cited by 53
“It was also found to be the most frequent Gram-negative bacterium recovered from patients with nosocomial pneumonia during ICU surveillance over the last two decades [3].”
BackgroundClinical and Economic Consequences of Ventilator‐Associated Pneumonia
Amin, A. (2009) · Clinical Infectious Diseases · doi:10.1086/599814 · Cited by 53
Current Concepts and Ongoing Research in the Prevention and Treatment of Open Fracture Infections
Hannigan, G. D., Pulos, N. A., Grice, E. A., & Mehta, S. D. (2014) · Advances in Wound Care · doi:10.1089/wound.2014.0531 · Cited by 53
Genetic basis of enzymatic resistance of E. coli to aminoglycosides
Ojdana, D., Sieńko, A., Sacha, P., Majewski, P., Wieczorek, P., Wieczorek, A., & Tryniszewska, E. A. (2017) · Advances in Medical Sciences · doi:10.1016/j.advms.2017.05.004 · Cited by 54
Ang, H., & Sun, X. (2018) · International Journal of Nursing Practice · doi:10.1111/ijn.12644 · Cited by 53
“Hospital‐acquired infections caused by antibiotic‐resistant Gram‐negative bacteria (GNB) are increasingly seen (Ivády et al., 2016).”
BackgroundKharsany, K., Viljoen, A. M., Leonard, C. M., & van Vuuren, S. F. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.111867 · Cited by 53
N-acyl homoserine lactone mediated interspecies interactions betweenA. baumanniiandP. aeruginosa
Bhargava, N., Sharma, P., & Capalash, N. (2012) · Biofouling · doi:10.1080/08927014.2012.714372 · Cited by 56
Hajjej, Z., Nasri, M., Sellami, W., Gharsallah, H., Labben, I., & Ferjani, M. (2013) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2013.08.001 · Cited by 52
Fihman, V., Monnier, A. L., Corvec, S., Jauréguy, F., Tankovic, J., Jacquier, H., Carbonnelle, É., Bille, E., Illiaquer, M., Cattoir, V., et al. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.01.001 · Cited by 52
Anti-Pseudomonas aeruginosa Vaccines and Therapies: An Assessment of Clinical Trials
Elmassry, M. M., Colmer‐Hamood, J. A., Kopel, J. J., Francisco, M. J. S., & Hamood, A. N. (2023) · Microorganisms · doi:10.3390/microorganisms11040916 · Cited by 53
Drawz, S. M., Taracila, M. A., Caselli, E., Prati, F., & Bonomo, R. A. (2011) · Protein Science · doi:10.1002/pro.612 · Cited by 52
“aeruginosa is also one of the most commonly isolated Gram-negative bacteria from patients in intensive care units in the United States, and the incidence has been rising during the past several decades.(3) Mortality rates up to 60% are reported for P.”
BackgroundTissot, F., Blanc, D., Basset, P., Zanetti, G. M. R., Berger, M. M., Que, Y., Eggimann, P., & Senn, L. (2016) · Journal of Hospital Infection · doi:10.1016/j.jhin.2016.05.011 · Cited by 51
Baicalin alleviated APEC-induced acute lung injury in chicken by inhibiting NF-κB pathway activation
Peng, L.-Y., Yuan, M., Song, K., Yu, J., Li, J., Huang, J., Yi, P.-F., Fu, B.-D., & Shen, H. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.04.046 · Cited by 51
Granato, E. T., Ziegenhain, C., Marvig, R. L., & Kümmerli, R. (2018) · The ISME Journal · doi:10.1038/s41396-018-0231-9 · Cited by 45
Peñaranda, C., Chumbler, N. M., & Hung, D. T. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009534 · Cited by 53
Naber, C. K., Baddour, L. M., Giamarellos‐Bourboulis, E. J., Gould, I. M., Herrmann, M., Hoen, B., Karchmer, A. W., Kobayashi, Y., Kozlov, R. S., Lew, D., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/598185 · Cited by 57
“Despite the increasing importance of gram-positive bacterial infections [1, 2] and, in particular, the clinical problems related to methicillin-resistant Staphylococcus aureus (MRSA) bacteremia [3–5], there is no international consensus on the diagnosis and management of”
BackgroundAspects of genome plasticity in pathogenic Escherichia coli
Bielaszewska, M., Dobrindt, U., Gärtner, J. F., Gallitz, I., Hacker, J. H., Karch, H., Müller, D., Schubert, S., Schmidt, M. A., Sorsa, L. J., et al. (2007) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2007.03.001 · Cited by 51
“Unfortunately, due to extreme heterogeneity of ExPEC populations and their increased resistance to antimicrobials, efficient identification and subsequent eradication of potentially pathogenic resident strains in patients at high-risk groups are difficult (Foxman et al., 2000; Gaynes and Edwards, 2005).”
BackgroundDiagnosis and Management of Bloodstream Infections With Rapid, Multiplexed Molecular Assays
Dunbar, S. A., Gardner, C. D., & Das, S. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.859935 · Cited by 56
Chen, C., Lin, L., Chang, Y., Chen, Y.-M., Chang, C., & Huang, C. (2015) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph120808871 · Cited by 50
Emerging Technologies for the Electrochemical Detection of Bacteria
McEachern, F., Harvey, E. J., & Merle, G. E. (2020) · Biotechnology Journal · doi:10.1002/biot.202000140 · Cited by 50
Tam, V. H., Chang, K., LaRocco, M., Schilling, A. N., McCauley, S. K., Poole, K., & Garey, K. W. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.05.006 · Cited by 49
“3%) for nosocomial urinary tract infection in the United States (Gaynes and Edwards, 2005).”
BackgroundNovel therapies for treatment of multi-drug resistantAcinetobacter baumanniiskin infections
Mihu, M. R., & Martinez, L. R. (2011) · Virulence · doi:10.4161/viru.2.2.15061 · Cited by 49
“The current clinical spectrum of Ab infections primarily encompasses diverse nosocomial illnesses, including intensive care unit (ICU)-acquired pneumonia, blood stream infections, urinary tract infections, meningitis and in rare cases, endocarditis.(1-5) Additionally, the microbe is responsible for the majority of com…”
BackgroundInfluentialRisk factors for carbapenem-resistant Gram-negative bacteremia in intensive care unit patients
Routsi, C., Pratikaki, M. E., Platsouka, E. D., Sotiropoulou, C., Papas, V., Pitsiolis, T., Tsakris, A., Nanas, S., & Roussos, C. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-2914-z · Cited by 49
Baker, M., Negus, D., Raghunathan, D., Radford, P. M., Moore, C., Clark, G., Diggle, M. A., Tyson, J., Twycross, J., & Sockett, R. E. (2017) · Scientific Reports · doi:10.1038/s41598-017-08060-4 · Cited by 49
Broquet, A. H., Jacqueline, C., Davieau, M., Besbes, A., Roquilly, A., Martin, J. P. D., Caillon, J., Dumoutier, L., Renauld, J., Heslan, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11518-0 · Cited by 50
Chen, L., Liu, Y., Hu, A., Chang, K., Lin, N., Lai, M., & Tseng, C. (2013) · BMC Microbiology · doi:10.1186/1471-2180-13-154 · Cited by 49
“It is an opportunistic pathogen with a wide spectrum of clinical manifestations, including pneumonia, meningitis, and blood stream, urinary tract, and wound infections [3,4].”
BackgroundAcinetobacter Infection in the ICU
Murray, C. K., & Hospenthal, D. R. (2008) · Critical Care Clinics · doi:10.1016/j.ccc.2007.12.005 · Cited by 49
“6% of urinary tract infections in 2003 [9].”
BackgroundLehti, T. A., Bauchart, P., Dobrindt, U., Korhonen, T., & Westerlund‐Wikström, B. (2012) · Microbiology · doi:10.1099/mic.0.056499-0 · Cited by 48
Nontoxic Cationic Coumarin Polyester Coatings Prevent Pseudomonas aeruginosa Biofilm Formation
Chamsaz, E. A., Mankoci, S., Barton, H. A., & Joy, A. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b12610 · Cited by 48
Zhang, B., Gu, J., Liu, J., Huang, B., & Li, J. (2019) · Medical Science Monitor · doi:10.12659/msm.919988 · Cited by 54
Ntusi, N., Badri, M., Khalfey, H., Whitelaw, A. C., Oliver, S., Piercy, J. L., Raine, R. I., Joubert, I., & Dheda, K. U. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052452 · Cited by 48
Deal, E. N., Micek, S. T., Ritchie, D. J., Reichley, R. M., Dunne, W. M., & Kollef, M. H. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.2.191 · Cited by 49
Mortality risk factors in patients with Acinetobacter baumannii ventilator-associated pneumonia
Chang, H., Chen, Y., Lin, M., Liu, S., Chung, Y., Su, M., Fang, W., Tseng, C., Lie, C.-H., Huang, K., et al. (2011) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2011.07.004 · Cited by 47
The Cytokine Response to Lipopolysaccharide Does Not Predict the Host Response to Infection
Fensterheim, B. A., Guo, Y., Sherwood, E. R., & Bohannon, J. K. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602106 · Cited by 52
El-Kazzaz, W. M., Metwally, L. A., Yahya, R. O., Alharbi, N. M., El-Taher, A., & Hetta, H. F. (2020) · Antibiotics · doi:10.3390/antibiotics9090603 · Cited by 47
“Recent clinical consideration has concentrated on the expanding rate of lactose non-fermenting, Gram-negative pathogens liable for health settings-gained infections [31].”
BackgroundYavari, N., Goltermann, L., & Nielsen, P. E. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.0c00822 · Cited by 47
Joseph, N. M., Bhanupriya, B., Shewade, D. G., & Harish, B. N. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/11029.5537 · Cited by 52
Kuo, F.-C., Wang, S.-M., Shen, C., Ma, Y.-J., Ho, T., Chen, J., Cheng, C., & Liu, C. (2015) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2015.08.013 · Cited by 46
Emergence and spread of multi-drug resistant organisms: Think globally and act locally
Tseng, S., Lee, C.-M., Lin, T., Chang, S., & Chang, F. (2011) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2011.03.001 · Cited by 49
Djordjevic, Z. M., Folić, M., Zivic, Z. P., Marković, V., & Јаnkovic, S. (2013) · American Journal of Infection Control · doi:10.1016/j.ajic.2013.02.018 · Cited by 46
Epidemiological Monitoring of Nosocomial Infections Caused by Acinetobacter Baumannii
Čustović, A., Smajlović, J., Tihić, N., Hadžić, S., Ahmetagić, S., & Hadzagić, H. (2014) · Medical Archives · doi:10.5455/medarh.2014.68.402-406 · Cited by 46
Manepalli, S., Gandhi, J. A., Ekhar, V. V., Asplund, M. B., Coelho, C., & Martinez, L. R. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.060004-0 · Cited by 46
Morrow, B. J., Pillar, C. M., Deane, J., Sahm, D. F., Lynch, A. S., Flamm, R. K., Peterson, J., & Davies, T. A. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.12.012 · Cited by 46
Korneev, K. V., Arbatsky, N. P., Molinaro, A., Palmigiano, A., Shaikhutdinova, R. Z., Shneider, M. M., Pier, G. B., Kondakova, A. N., Sviriaeva, E. N., Sturiale, L., et al. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00595 · Cited by 46
Magira, E. E., Islam, S., & Niederman, M. S. (2017) · Medicina Intensiva · doi:10.1016/j.medin.2017.07.006 · Cited by 46
Recent Advancements in the Technologies Detecting Food Spoiling Agents
Saini, R. V., Vaid, P., Saini, N. K., Siwal, S. S., Gupta, V. K., Thakur, V. K., & Saini, A. K. (2021) · Journal of Functional Biomaterials · doi:10.3390/jfb12040067 · Cited by 51
Endimiani, A., Luzzaro, F., Pini, B., Amicosante, G., Rossolini, G. M., & Toniolo, A. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-52 · Cited by 46
Webster, T. J., Wang, & Perez (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s50292 · Cited by 46
Zuccheri, T., Colonna, M., Stefanini, I., Santini, C., & Gioia, D. D. (2013) · Materials · doi:10.3390/ma6083270 · Cited by 46
Kahvecioglu, D. C., Ramiah, K., McMaughan, D. J., Garfinkel, S., McSorley, V. E., Nguyen, Q. N., Yang, M., Pugliese, C., Mehr, D. R., & Phillips, C. D. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/677835 · Cited by 46
Broad Identification of Bacterial Type in Urinary Tract Infection Using 1H NMR Spectroscopy
Gupta, A. K., Dwivedi, M., Mahdi, A. A., Khetrapal, C. L., & Bhandari, M. (2012) · Journal of Proteome Research · doi:10.1021/pr2010692 · Cited by 45
De-Escalation Therapy: Is It Valuable for the Management of Ventilator-Associated Pneumonia?
Niederman, M. S., & Soulountsi, V. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.05.009 · Cited by 48
Sainis, I., Banti, C. N., Owczarzak, A. M., Kyros, L., Kourkoumelis, N., Kubicki, M., & Hadjikakou, S. K. (2015) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2015.12.013 · Cited by 45
Acinetobacter: Microbiological, Pathogenetic and Resistant Properties
Chebotar, I. V., Lazareva, A., Masalov, Y. K., Mikhailovich, V. M., & Mayanskiy, N. A. (2014) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn.v69i9-10.1130 · Cited by 45
“baumannii колеблется, по одним данным, от 8 до 32%, по другим — от 19 до 54% [18, 64].”
Peluso, L., de Luca, C., Bozza, S., Leonardi, A., Giovannini, G., Lavorgna, A., Rosa, G. D., Mascolo, M., Luna, L. O. D., Catania, M. R., et al. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-9 · Cited by 49
“Pseudomonas aeruginosa, an ubiquitous environmental Gram-negative microrganism, is one of most important opportunistic bacteria in hospital-acquired infections [ 1-3 ].”
BackgroundSerratamolide is a Hemolytic Factor Produced by Serratia marcescens
Shanks, R. M. Q., Stella, N. A., Lahr, R. M., Wang, S., Veverka, T. I., Kowalski, R. P., & Liu, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036398 · Cited by 45
Healthcare‐associated Infections: Epidemiology, Prevention, and Therapy
Doshi, R. K., Patel, G., MacKay, R., & Wallach, F. R. (2009) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20070 · Cited by 58
Cloutier, M., Tolouei, R., Lesage, O., Lévesque, L., Turgeon, S., Tatoulian, M., & Mantovani, D. (2014) · Biointerphases · doi:10.1116/1.4871435 · Cited by 48
Risk factors and management of Gram-positive bacteraemia
Cervera, C., Almela, M., Martínez-Martínez, J. A., Moreno, A., & Miró, J. M. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(09)70562-x · Cited by 49
Asmarawati, T. P., Rosyid, A. N., Suryantoro, S. D., Mahdi, B. A., Windradi, C., Wulaningrum, P. A., Arifijanto, M. V., Bramantono, B., Triyono, E. A., Rusli, M., et al. (2021) · F1000Research · doi:10.12688/f1000research.31645.1 · Cited by 44
“In intensive care units (ICUs), gram-negative bacteria account for about 70% of these types of infections 25 .”
Key considerations in the treatment of complicated staphylococcal infections
Jones, R. N. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01923.x · Cited by 22
“This trend is especially apparent for bloodstream infections, where Gram-positive pathogens can account for up to 70% of infections, and for surgical site infections, where the predominant cause has shifted from Gram-negative bacteria to Gram-positive bacteria over the past 20 years [4].”
BackgroundTang, M., Odejinmi, S. I., Allette, Y. M., Vankayalapati, H., & Lai, K. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.08.012 · Cited by 44
“Currently, more than half of all nosocomial infections are caused by Gram-negative bacteria [1].”
BackgroundRay, L., Levasseur‐Franklin, K. E., Nicolau, D. P., & Scheetz, M. H. (2010) · Annals of Pharmacotherapy · doi:10.1345/aph.1m480 · Cited by 46
Current challenges in the management of the infected patient
Nicolau, D. P. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/01.qco.0000393483.10270.ff · Cited by 50
Badamchi, A., Masoumi, H., Javadinia, S., Asgarian, R., & Tabatabaee, A. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.03.009 · Cited by 44
Singh, M. K., Yau, Y. C. W., Wang, S. V., Waters, V. J., & Kumar, A. (2017) · Canadian Journal of Microbiology · doi:10.1139/cjm-2017-0380 · Cited by 50
Luyt, C. E., Eldon, M. A., Staß, H., Gribben, D., Corkery, K. J., & Chastre, J. E. (2011) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2010.0860 · Cited by 43
Park, Y. S., Lee, H., Chin, B. S., Han, S. H., Chong, Y., Hong, S. K., Kim, H., Uh, Y., Shin, H. B., Choo, E. J., et al. (2011) · Journal of Hospital Infection · doi:10.1016/j.jhin.2011.05.014 · Cited by 43
Management of febrile neutropenia in the era of bacterial resistance
Alp, Ş., & Akova, M. (2013) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936113475610 · Cited by 49
“…pathogens are reported to be etiologic agents of infections unresponsive to carbapenems [Aubron et al. 2005; Cattaneo et al. 2008; Chen et al. 2004; Freifeld et al. 2011; Gaynes and Edwards, 2005; Gudiol et al. 2011, 2012; Hakki et al. 2007; Kontoyiannis et al. 2009; Oliveira et al. 2007].”
BackgroundJoung, M. K., Kwon, K. T., Kang, C., Cheong, H. S., Rhee, J.-Y., Jung, D. S., Chung, S. M., Lee, J. A., Moon, S., Ko, K. S., et al. (2010) · Journal of Infection · doi:10.1016/j.jinf.2010.06.014 · Cited by 43
Goto, M., O'Shea, A. M. J., Livorsi, D. J., McDanel, J. S., Jones, M. M., Richardson, K. K., Beck, B. F., Alexander, B., Evans, M. E., Roselle, G. A., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw423 · Cited by 43
Rao, G. G., Ly, N. S., Bulitta, J. B., Soon, R. L., Roman, M. D. S., Holden, P. N., Landersdorfer, C. B., Nation, R. L., Li, J., Forrest, A., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw293 · Cited by 43
Granato, E. T., Harrison, F., Kümmerli, R., & Ross‐Gillespie, A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01952 · Cited by 45
“Opportunistic pathogens underlie many hospital-acquired infections, especially in immune-compromised patients (Gaynes and Edwards, 2005; Obritsch et al., 2005; Länger and Kreipe, 2011), and the treatment of such infections is often challenging because, as generalists, such pathogens are…”
BackgroundSchaefers, M. M., Duan, B., Mizrahi, B., Lu, R., Reznor, G., Kohane, D. S., & Priebe, G. P. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.10.010 · Cited by 43
Quantitative Impact of Neutrophils on Bacterial Clearance in a Murine Pneumonia Model
Guo, B., Abdelraouf, K., Ledesma, K. R., Chang, K., Nikolaou, M., & Tam, V. H. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00508-11 · Cited by 43
“Multidrug resistance in both species has been increasing over the past decades and correlates with significant morbidity and mortality (3, 6).”
BackgroundEagye, K. J., Kuti, J. L., & Nicolau, D. P. (2009) · Infection Control and Hospital Epidemiology · doi:10.1086/603527 · Cited by 57
The Capsule of Acinetobacter baumannii Protects against the Innate Immune Response
Akoolo, L., Pires, S., Kim, J., & Parker, D. (2022) · Journal of Innate Immunity · doi:10.1159/000522232 · Cited by 46
Elfaky, M. A., Elbaramawi, S. S., Eissa, A. G., Ibrahim, T. S., Khafagy, E., Ali, M. A. M., & Hegazy, W. A. H. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12522-3 · Cited by 43
“2010; Cornelis 2006; Filloux 2011; Gellatly and Hancock 2013).”
BackgroundZhang, L., Keogh, S. J., & Rickard, C. M. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s50312 · Cited by 46
Mendes, R. E., Castanheira, M., Woosley, L. N., Stone, G. G., Bradford, P. A., & Flamm, R. K. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02447-16 · Cited by 42
“K. pneumoniae isolates had group-1 CTX-M variants (i.e., 1 blaCTX-M-3 and 25 blaCTX-M-15), including one strain each that also had blaOXA-48, blaNDM-1, and blaNDM-4 (Table 2).”
BackgroundInfluentialAinsworth, S., Ketter, P. M., Yu, J., Grimm, R. C., May, H. C., Cap, A. P., Chambers, J. P., Guentzel, M. N., & Arulanandam, B. P. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.05.017 · Cited by 42
Peptide nucleic acids (PNAs): currently potential bactericidal agents.
Narenji, H., Gholizadeh, P., Aghazadeh, M., Rezaee, M. A., Asgharzadeh, M., & Kafil, H. S. (2017) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2017.06.092 · Cited by 36
Wuerth, K. C., Falsafi, R., & Hancock, R. E. W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187565 · Cited by 43
Metadata
- Authors
- Weinstein, R. A., Gaynes, R., Edwards, J. R., & System, N. N. I. S.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-15
- Volume
- 41
- Issue
- 6
- Pages
- 848-854
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2151958462
- Cited by
- 1,404
- References
- 26
- Citations by year
- 2026: 14 · 2025: 21 · 2024: 37 · 2023: 56 · 2022: 73 · 2021: 80 · 2020: 66 · 2019: 78 · 2018: 66 · 2017: 74 · 2016: 86 · 2015: 89 · 2014: 85 · 2013: 95 · 2012: 85
- FWCI
- 38.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
- Keywords
- nosocomial infections, Gram-negative bacilli, intensive care unit, surgical site infection, urinary tract infection, bloodstream infection, Acinetobacter, antimicrobial resistance, epidemiological trends
- MeSH terms
- Cross Infection, Gram-Negative Bacteria, Humans, National Health Programs, Population Surveillance, Surgical Wound Infection, Time Factors, United States, Urinary Tract Infections, Gram-Negative Bacterial Infections, Pneumonia, Bacterial, Sepsis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.